Principal Investigator
|
Title
|
Organization
|
Status
|
ID
|
| Pluschke, Gerd |
Helminth-coinfection |
Molecular Immunology (Pluschke) |
Completed |
1034070 |
| Pluschke, Gerd |
Herstellung und Charakterisierung von monoklonalen Antikörpern gegen bakterielle Agenzien |
Molecular Immunology (Pluschke) |
Completed |
1034069 |
| Pluschke, Gerd |
Malaria Antigen |
Molecular Immunology (Pluschke) |
Completed |
1034066 |
| Daubenberger, Claudia; Tanner, Marcel; Genton, Blaise |
Dissecting the immunological interplay between poverty related diseases and helminth infections: an african-european research inititative |
Molecular Immunology (Pluschke),
Malaria Interventions (Lengeler) |
Completed |
1034064 |
| Daubenberger, Claudia |
Phase II Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of H1, an adjuvanted TB subunit vaccine in HIV-infected, BCG-vaccinated Adults With CD4+ Lymphocyte Counts Greater Than 350 Cells/mm3 |
Molecular Immunology (Pluschke) |
Completed |
1034063 |
| Pluschke, Gerd |
Wound Healing |
Molecular Immunology (Pluschke) |
Completed |
1034047 |
| Pluschke, Gerd |
Genome-driven vaccine development for bacterial infections |
Molecular Immunology (Pluschke) |
Completed |
1034046 |
| Pluschke, Gerd |
Buruli ulcer: Development and evaluation of innovative tools |
Molecular Immunology (Pluschke) |
Completed |
1034045 |
| Tanner, Marcel; Daubenberger, Claudia |
Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a phase III double-blind randomized controlled multi-center trial |
Molecular Immunology (Pluschke) |
Completed |
1034028 |
| Daubenberger, Claudia |
Monitoring antibody responses by nanomechanical cantilever array sensors |
Molecular Immunology (Pluschke) |
Completed |
1034026 |
| Daubenberger, Claudia |
Sustainable livelihoods of Tanzanian pastoralist communities through integrated animal – human health research and interventions |
Molecular Immunology (Pluschke) |
Completed |
1034025 |
| Pluschke, Gerd |
ACBRIDGE - PhD Program with the University of Ghana |
Molecular Immunology (Pluschke) |
Completed |
1034024 |
| Pluschke, Gerd |
Buruli Vac - Identification and development of vaccine candidates for Buruli Ulcer Disease |
Molecular Immunology (Pluschke) |
Completed |
1033982 |
| Daubenberger, Claudia |
Genome profiling of Theileria parva isolates |
Molecular Immunology (Pluschke) |
Completed |
1033963 |
| Daubenberger, Claudia |
Exploration of the effects of anti-tick vaccines on transmission of Theileria parva |
Molecular Immunology (Pluschke) |
Completed |
1033962 |
| Pluschke, Gerd |
Thermotherapy of Buruli ulcer (extension) |
Molecular Immunology (Pluschke) |
Completed |
1033961 |
| Pluschke, Gerd |
Meningitis surveillance (extension) |
Molecular Immunology (Pluschke) |
Completed |
1033960 |
| Pluschke, Gerd |
DNA methylation and virulence of Neisseria meningitidis |
Molecular Immunology (Pluschke) |
Completed |
1033923 |
| Pluschke, Gerd |
Buruli ulcer – neglected disease |
Molecular Immunology (Pluschke) |
Completed |
1033912 |
| Pluschke, Gerd |
STOP Buruli consortium |
Molecular Immunology (Pluschke) |
Completed |
1033911 |
